Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

City of Hope

1500 E. Duarte Road     
Duarte , CA 91010
USA

 

Principal Investigator:
Warren Chow, MD
Contact:
Neeti Arora 626-256-4673 xt 63019 narora@coh.org
Activation Status of this Site:
Closed
Notes about this Site:
City of Hope Website:
http://clinicaltrials.coh.org/specific_search.aspx

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.